Showing results (11-20 of 326) with videos related to
Sort By:
Pageof 33
Expert Review of Neurotherapeutics|July 24, 2024
An overview of the currently available and emerging long-acting formulations of risperidone for schizophrenia and bipolar disorderJustin Faden, Camila Ramirez, Vanessa Martinez, et al.Expert Opinion on Pharmacotherapy|November 30, 2020
Does antipsychotic combination therapy reduce the risk of hospitalization in schizophrenia?Justin Faden, Natasha Kiryankova-Dalseth, Ruby Barghini, et al.Neuropsychiatric Disease and Treatment|April 3, 2024
Efficacy of HP-3070, A Once-Daily Asenapine Transdermal System, in the Treatment of Adults with Schizophrenia: A PANSS Five-Factor AnalysisLeslie Citrome, Mariacristina Castelli, Masami Hasebe, et al.Postgraduate Medicine|August 3, 2010
Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmedLeslie CitromeJournal of the Neurological Sciences|March 10, 2018
Reprint of: Clinical management of tardive dyskinesia: Five steps to successLeslie CitromeCNS Spectrums|June 15, 2019
Binge eating disorder revisited: what's new, what's different, what's nextLeslie CitromePostgraduate Medicine|January 4, 2003
Atypical antipsychotics for acute agitation. New intramuscular options offer advantagesLeslie CitromeAdvances in Therapy|January 31, 2013
Cariprazine in schizophrenia: clinical efficacy, tolerability, and place in therapyLeslie CitromeExpert Review of Neurotherapeutics|August 1, 2013
New second-generation long-acting injectable antipsychotics for the treatment of schizophreniaLeslie CitromePageof 33